Del Castillo Katz model
Del Castillo Katz model is a mathematical model used in the field of pharmacology to describe the interaction between drugs and receptors. It was developed by Juan del Castillo and Bernard Katz in 1957.
Overview[edit | edit source]
The Del Castillo Katz model is an extension of the Langmuir isotherm and is used to describe the binding of ligands to receptors. It assumes that the receptor can exist in two states, active and inactive, and that the ligand can bind to both states. The model is characterized by four rate constants: the association and dissociation rates for the ligand binding to the active and inactive states.
Mathematical Formulation[edit | edit source]
The Del Castillo Katz model is described by the following set of differential equations:
- d[R]/dt = k1[L][R] - k2[LR] + k5[LR*] - k6[R]
- d[LR]/dt = k2[LR] - k1[L][R] + k4[LR*] - k3[LR]
- d[LR*]/dt = k3[LR] - k4[LR*] + k6[R] - k5[LR*]
where [R] is the concentration of the receptor in the inactive state, [LR] is the concentration of the ligand-receptor complex in the inactive state, [LR*] is the concentration of the ligand-receptor complex in the active state, [L] is the concentration of the free ligand, and k1, k2, k3, k4, k5, and k6 are the rate constants.
Applications[edit | edit source]
The Del Castillo Katz model is widely used in pharmacology to study the effects of drugs on the body. It can be used to predict the response of a receptor to a drug, and to design new drugs with desired properties. The model is also used in biochemistry to study the binding of ligands to proteins.
See Also[edit | edit source]
References[edit | edit source]
- Del Castillo, J., & Katz, B. (1957). Interaction at end-plate receptors between different choline derivatives. Proceedings of the Royal Society of London. Series B - Biological Sciences, 146(924), 369–381.
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD